ArticleJournal of neurology2025
Thrombolysis-to-recanalization time and clinical outcomes in large-vessel occlusion patients with successful recanalization.
Article in Journal of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
objectiveThe benefit of intravenous thrombolysis (IVT) before endovascular treatment (EVT) in patients with anterior circulation large-vessel occlusion (LVO) remains unclear. This study aimed to determine whether thrombolysis-to-recanalization time (TRT) can affect the benefit of IVT.
methodsFrom the DETECT2-China registry cohort, patients with anterior circulation LVO who achieved complete reperfusion after IVT and bridging EVT were included. Based on TRT corresponding to the minimum adjusted odds ratio (aOR) associated with favorable functional outcome on the restricted cubic spline (RCS), patients were divided into two groups: TRT ≤ 170 min and TRT > 170 min. The primary efficacy outcome was a favorable functional outcome, defined as mRS 0 to 2 at 90 days. Clinical outcomes were compared in the original cohort and in a cohort matched using inverse probability of treatment weighting (IPTW).
resultsA total of 167 eligible patients were included in the final analysis, comprising 82 in the TRT ≤ 170 min group and 85 in the TRT > 170 min group. In the original cohort, TRT ≤ 170 min group had a higher rate of favorable functional outcome (70.7% vs. 50.6%, aOR = 2.919, 95% CI 1.204-7.416, P = 0.020), excellent functional outcome (59.8% vs. 40%, aOR = 2.856, 95% CI 1.225-6.912, P = 0.017). Similar results were found in the IPTW-matched cohort. Furthermore, The restricted cubic spline analysis revealed a linear association between TRT and favorable functional outcome at 90 days (P for linearity = 0.019).
conclusionIn patients with acute anterior circulation LVO stroke who received IVT-bridging EVT and achieved complete reperfusion post-procedural angiography, there may be a time-dependent benefit of IVT associated with TRT. Shorter TRT may be associated with better clinical outcomes.
Indexed as
Identifiers
41076615What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.